Edition:
United Kingdom

Tracon Pharmaceuticals Reports Qtrly Loss Per Share $0.24


Tuesday, 14 May 2019 

May 14 (Reuters) - TRACON Pharmaceuticals Inc ::TRACON PHARMACEUTICALS REPORTS FIRST QUARTER 2019 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE.TRACON PHARMACEUTICALS INC - CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS WERE $32.1 MILLION AT MARCH 31, 2019, COMPARED TO $39.1 MILLION AT DECEMBER 31.TRACON PHARMACEUTICALS INC - EXPECT CURRENT CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS TO FUND OPERATIONS INTO Q3 OF 2020.TRACON PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.24.TRACON PHARMACEUTICALS INC - COLLABORATION REVENUE WAS $0 FOR Q1 OF 2019 COMPARED TO $3.0 MILLION FOR Q1 OF 2018. 

Company Quote

0.5401
-0.0158 -2.84%
22 Jul 2019